Skip to main content

Advertisement

Table 5 Logistic regression analysis to assess the association of MMP-9 expression and PTC, TNM stages, and lymphovascular invasion

From: The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer

  B S.E. P value Odds ratio 95% Confidence Interval
Patients PTC vs. MNG MMP-9a 0.18 0.07 0.009 1.20 (1.04–1.37)
TNM Stages III/IV vs. I/II MMP-9a 0.61 0.31 0.050 1.83 (0.99–3.37)
Lymphovascular invasion Yes vs. No MMP-9 1.38 0.44 0.002 3.97 (1.68–9.40)
  1. aAdjusted for age and sex